Riskified (NYSE: RSKD) insider plans Rule 144 sale of 5,000 Class A shares

Rhea-AI Filing Summary

RSKD received a notice of proposed share sales under Rule 144. An affiliated holder plans to sell 5,000 Class A ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of 24,950.00. The filing notes that 112,306,279 Class A ordinary shares were outstanding at the time of the notice, providing context for the sale size.

The seller originally acquired 714,237 Class A ordinary shares in a private placement from the issuer on 07/13/2017 for cash. Over the prior three months, Genesis Partners IV LP reported several sales of Class A ordinary shares, including 6,089, 35,871, and 37,936 shares for gross proceeds of 30,155.53, 172,686.58, and 185,465.31, respectively. The signer represents they are not aware of undisclosed material adverse information about the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	5000	24950.00	112306279	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A ordinary	07/13/2017	Private Placement	Isuuer			714237	07/13/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GENESIS PARTNERS IV LP 220 5TH AVENUE 2ND FLOOR NEW YORK NY 10004	Class A ordinary	11/28/2025	6089	30155.53
GENESIS PARTNERS IV LP 220 5TH AVENUE 2ND FLOOR NEW YORK NY 10004	Class A ordinary	12/04/2025	35871	172686.58
GENESIS PARTNERS IV LP 220 5TH AVENUE 2ND FLOOR NEW YORK NY 10004	Class A ordinary	12/05/2025	37936	185465.31

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for RSKD disclose?

The filing discloses that an affiliate intends to sell 5,000 Class A ordinary shares of RSKD on the NYSE through Oppenheimer & Co. Inc., with an aggregate market value of 24,950.00.

How many RSKD shares are currently outstanding according to this notice?

The notice states that there were 112,306,279 Class A ordinary shares of RSKD outstanding when the proposed sale was reported.

When and how were the RSKD shares being sold originally acquired?

The Class A ordinary shares were acquired on 07/13/2017 in a private placement from the issuer, with 714,237 shares purchased for cash.

What recent sales of RSKD shares by Genesis Partners IV LP are reported?

Over the past three months, Genesis Partners IV LP reported selling Class A ordinary shares in three transactions: 6,089 shares on 11/28/2025, 35,871 shares on 12/04/2025, and 37,936 shares on 12/05/2025, for gross proceeds of 30,155.53, 172,686.58, and 185,465.31, respectively.

What representation does the seller make about RSKD in this Form 144?

The seller represents that they do not know any material adverse information about the current or prospective operations of the issuer that has not been publicly disclosed.

Which broker is handling the proposed RSKD share sale?

The proposed sale of 5,000 Class A ordinary shares is to be handled by Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004.